PIC Therapeutics

company

About

PIC Therapeutics is a biotechnology company focused on transforming the treatment of cancer.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$35M
Industries
Biotechnology,Health Care,Medical,Therapeutics
Founded date
Jan 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

PIC Therapeutics is a biotechnology company focused on transforming the treatment of cancer through the selective modulation of oncogene translation. The company is modulating oncogene translation to dramatically improve cancer patient outcomes. Their precision-based therapeutics target the “master switch” of cancer signaling pathways, selectively blocking oncogene protein production by modulating the Pre-Initiation Complex (PIC) that drives their mRNA translation. Its selective approach has the potential to simultaneously modulate multiple oncogenic drivers leading to a powerful new generation of cancer-treating therapeutics.

PIC Therapeutics was founded in 2016 and is headquartered in Natick, Massachusetts, United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$35M
PIC Therapeutics has raised a total of $35M in funding over 2 rounds. Their latest funding was raised on Oct 19, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 19, 2022 Series A $35M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
PIC Therapeutics is funded by 1 investors. Harrington Discovery Institute at University Hospitals are the most recent investors.
Investor Name Lead Investor Funding Round
Harrington Discovery Institute at University Hospitals Series A